A cytokine with both pro- and anti-inflammatory roles depending on context. Produced by immune and non-immune cells, it is widely elevated in chronic inflammatory and autoimmune diseases and is a commonly used biomarker of inflammatory activity.
IL-6 is notable for its versatility: it acts as a pro-inflammatory signal in acute infection, yet also has regulatory and anti-inflammatory roles in other contexts, including exercise-induced responses. This dual nature makes it a complex but commonly measured marker.
Elevated IL-6 is found in rheumatoid arthritis, inflammatory bowel disease, severe COVID-19, and many other conditions. IL-6 receptor antagonists (such as tocilizumab) are used therapeutically in some autoimmune diseases.
In vagus nerve and cholinergic pathway research, IL-6 is among the cytokines measured to assess the degree of inflammatory suppression achieved through nerve stimulation.